Federal Trade Commission Cracks Down on Fake Charities For Exploiting Support for Veterans. Find Out More
by Leigh Purvis, Public Policy Institute, October 2011|Comments: 0
In the United States, spending on expensive biologic drugs is growing more than ten times faster than spending on traditionally-developed “small molecule” drugs. This AARP Public Policy Institute fact sheet by Leigh Purvis examines provisions in the Affordable Care Act that created an approval pathway for generic versions of biologic drugs, or biosimilars, but ensured that brand name biologic manufacturers are protected from this new competition for at least 12 years. Drug manufacturer sales data show that most top-selling biologics can recoup their manufacturer’s development costs in a single year.
Please leave your comment below.
You must be logged in to leave a comment.
Members save on eye exams and eyewear at participating locations.
Members earn points on select Walgreens brand health and wellness products.
Free telephone-administered confidential hearing test for AARP members.
AARP members receive exclusive member benefits & affect social change.
You are leaving AARP.org and going to the website of our trusted provider. The provider’s terms, conditions and policies apply. Please return to AARP.org to learn more about other benefits.
Your email address is now confirmed.
Manage your email preferences and tell us which topics interest you so that we can prioritize the information you receive.
Explore all that AARP has to offer.
In the next 24 hours, you will receive an email to confirm your subscription to receive emails
related to AARP volunteering. Once you confirm that subscription, you will regularly
receive communications related to AARP volunteering. In the meantime, please feel free
to search for ways to make a difference in your community at